NervGen Pharma Corp - ESG Rating & Company Profile powered by AI
This webpage is a zero-cost ESG report for NervGen Pharma Corp. The article contains a Q&A table about NervGen Pharma Corp. This Sustainability rating for NervGen Pharma Corp represents its transparency towards the UN SDGs.
NervGen Pharma Corp in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.9; made up of an environmental score of 5.3, social score of 6.4 and governance score of 6.0.
5.9
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 498 | Redx Pharma PLC | 6.0 | High |
| 498 | Vimta Labs Ltd | 6.0 | High |
| 521 | NervGen Pharma Corp | 5.9 | High |
| 521 | Cellink AB | 5.9 | High |
| 521 | Celon Pharma SA | 5.9 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does NervGen Pharma Corp have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes NervGen Pharma Corp disclose current and historical energy intensity?
Sign up for free to unlockDoes NervGen Pharma Corp report the average age of the workforce?
Sign up for free to unlockDoes NervGen Pharma Corp reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes NervGen Pharma Corp disclose its ethnicity pay gap?
Sign up for free to unlockDoes NervGen Pharma Corp disclose cybersecurity risks?
Sign up for free to unlockDoes NervGen Pharma Corp offer flexible work?
Sign up for free to unlockDoes NervGen Pharma Corp have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes NervGen Pharma Corp disclose the number of employees in R&D functions?
Sign up for free to unlockDoes NervGen Pharma Corp conduct supply chain audits?
Sign up for free to unlockDoes NervGen Pharma Corp disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes NervGen Pharma Corp conduct 360 degree staff reviews?
Sign up for free to unlockDoes NervGen Pharma Corp disclose the individual responsible for D&I?
Sign up for free to unlockDoes NervGen Pharma Corp disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes NervGen Pharma Corp disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes NervGen Pharma Corp disclose water use targets?
Sign up for free to unlockDoes NervGen Pharma Corp have careers partnerships with academic institutions?
Sign up for free to unlockDid NervGen Pharma Corp have a product recall in the last two years?
Sign up for free to unlockDoes NervGen Pharma Corp disclose incidents of discrimination?
Sign up for free to unlockDoes NervGen Pharma Corp allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas NervGen Pharma Corp issued a profit warning in the past 24 months?
Sign up for free to unlockDoes NervGen Pharma Corp disclose parental leave metrics?
Sign up for free to unlockDoes NervGen Pharma Corp disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes NervGen Pharma Corp disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes NervGen Pharma Corp disclose the pay ratio of women to men?
Sign up for free to unlockDoes NervGen Pharma Corp support suppliers with sustainability related research and development?
Sign up for free to unlockDoes NervGen Pharma Corp disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes NervGen Pharma Corp reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs NervGen Pharma Corp involved in embryonic stem cell research?
Sign up for free to unlockDoes NervGen Pharma Corp disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes NervGen Pharma Corp disclose its waste policy?
Sign up for free to unlockDoes NervGen Pharma Corp report according to TCFD requirements?
Sign up for free to unlockDoes NervGen Pharma Corp disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes NervGen Pharma Corp disclose energy use targets?
Sign up for free to unlockDoes NervGen Pharma Corp disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes NervGen Pharma Corp have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for NervGen Pharma Corp
These potential risks are based on the size, segment and geographies of the company.
NervGen Pharma Corp., a clinical stage biotech company, discovers and develops treatments for patients suffering from medical conditions related to nerve damage. Its lead product candidate is the NVG-291 that is in clinical studies for the treatment of spinal cord injuries (SCI), multiple sclerosis, and Alzheimer's disease. The company has a licensing agreement with Case Western Reserve University to research, develop, and commercialize a patented technology with therapeutic potential for SCI and other conditions associated with nerve damage. The company was incorporated in 2017 and is headquartered in Vancouver, Canada.